Efficacy and safety of carrimycin in ten patients with severe pneumonia following solid organ transplantation

doi:10.12998/wjcc.v12.i15.2542

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1147)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

HTML

656

Figures (1-2)

117

Tables (1-5)

Sum=898

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

159

Sum=199

May 26, 2024 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. May 26, 2024; 12(15): 2542-2550
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2542

Efficacy and safety of carrimycin in ten patients with severe pneumonia following solid organ transplantation

Xian-Quan Cui, Lu-Wei Zhang, Peng Zhao, Jing-Jing Feng

Xian-Quan Cui, Peng Zhao, Department of Organ Transplantation, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China

Lu-Wei Zhang, Jing-Jing Feng, Department of Blood Purification, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China

Author contributions: Cui XQ and Zhang LW designed this study and wrote the manuscript; Zhao P participated in collection and analysis of data; Feng JJ reviewed and revised the manuscript. All authors read and approved the final manuscript.

Institutional review board statement: The study was reviewed and approved by Qilu Hospital of Shandong University Institutional Review Board (Approval No. KYLL-202306-099).

Informed consent statement: The study was reviewed and approved for exemption from informed consent by the Institutional Review Board of Qilu Hospital, Shandong University.

Conflict-of-interest statement: All the authors declare that they have no conflict of interest.

Data sharing statement: All data are kept by the corresponding author and can be released upon reasonable request.

STROBE statement: The authors have read the STROBE Statement -checklist of items, and the manuscript was prepared and revised according to the STROBE Statement- checklist of items.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Jing-Jing Feng, MBBS, Doctor, Department of Blood Purification, Qilu Hospital of Shandong University, No. 107 Wenhua West Road, Jinan 250012, Shandong Province, China. feng.jing.jing@126.com

Received: January 25, 2024
Peer-review started: January 25, 2024
First decision: February 8, 2024
Revised: February 24, 2024
Accepted: March 28, 2024
Article in press: March 28, 2024
Published online: May 26, 2024
Processing time: 110 Days and 3.5 Hours

Core Tip

Core Tip: In this study, the clinical features and treatment projects of 10 cases of severe pneumonia (SP) after solid organ transplantation were retrospectively analyzed. It was conformed that carrimycin is a safe and effective modality in the treatment of SP after solid organ transplantation.